Table I.
CBX3/HP1γ expression | ||||
---|---|---|---|---|
Variables | Cases | Lowa | High | χ2 P-value |
Age | 0.182 | |||
<60 | 81 | 28 | 53 | |
≥60 | 45 | 21 | 24 | |
Gender | 0.273 | |||
Male | 80 | 34 | 46 | |
Female | 46 | 15 | 31 | |
Smoking | 0.745 | |||
Yes | 64 | 24 | 40 | |
No | 62 | 25 | 37 | |
Tumor size | 0.843 | |||
T1–2 | 107 | 42 | 65 | |
T3-4 | 19 | 7 | 12 | |
Pathological grade | 0.824 | |||
G1 | 99 | 38 | 61 | |
G2-3 | 27 | 11 | 16 | |
Cervical node metastasis | 0.010 | |||
N- | 89 | 41 | 48 | |
N+ | 37 | 8 | 29 | |
Clinical stage | 0.025 | |||
I–II | 80 | 37 | 43 | |
III–IV | 46 | 12 | 34 |
Both of patients with low and negative CBX3/HP1γ staining are stratified into low category for simplicity. TSCC, tongue squamous cell carcinoma.